tirzepatide and ckd for Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, Anti-Obesity Medications Among Tirzepatide and Kidney Disease: Safety

Diabetic patients treated with semaglutide (Ozempic) showed dose-dependent weight loss with an average ~6 kg at a 2 mg dose with 40% of patients losing more than 10% of their weight (1)

While they work well for some users, they may increase appetite more than desired

Most patients find the needle to be very thin and the process relatively painless

Oral options expand choice and may improve real-world acceptance

I felt valued and supported by the entire team

RETURN TO TOP March 14, 2012: AKC's CHIC program is a farce for cavaliers Don't be fooled by cavalier breeders who brag about CHIC The American Kennel Club* (AKC) sponsors the Canine Health Information Center, also known as CHIC, with the stated mission "To provide a source of health information for owners, breeders, and scientists, that will assist in breeding healthy dogs." Unfortunately, for the cavalier King Charles spaniel, CHIC not only does not work